Science news

Kerico Health Care Expands Non-Emergency Medical Transportation Services to Arkansas Following 300% Year-Over-Year Growth in Texas

Kerico Health Care Expands Vital Non-Emergency Medical Transportation (NEMT) Services to Seniors in Arkansas Following Remarkable Success in Texas HOUSTON, Dec. 2, 2023 /PRNewswire-PRWeb/ --...

Climate Philanthropies Announce $450 Million to Deepen Investment in Super Climate Pollutants

Commitment will complement crucial decarbonization efforts to help reduce near-term warming DUBAI, United Arab Emirates, Dec. 2, 2023 /PRNewswire/ -- Today at COP28, leading climate philanthropies...

India EV Charging Station Market Report 2023-2028 – Government Support and Green Energy Drive Demand

DUBLIN, Dec. 1, 2023 /PRNewswire/ -- The "EV Charging Station Market in India 2023 - 2028" report has been added to  ResearchAndMarkets.com's offering. In FY 2023,...

Gene therapy market size to grow by USD 4,613.9 million from 2022 to 2027 | Growing research in gene therapy for CVDs and orphan...

NEW YORK, Dec. 1, 2023 /PRNewswire/ -- Technavio categorizes the global gene therapy market size as estimated to increase by USD 4,613.9 million between 2022 and...

Cerecin forges strategic partnership with A*STAR's Institute of Molecular and Cell Biology (IMCB) in Singapore to advance R&D in neurological disorders.

Cerecin and IMCB signed a Memorandum of Understanding to collaborate in the areas of neurometabolism, neurodegeneration, metabolic regulators, and brain health and function. SINGAPORE and DENVER,...

Agroecology Fund Receives Largest Investment to Date to Accelerate Community-Led Global Climate Solutions

Waverley Street Foundation to invest $16 million over four years to strengthen global agroecology and climate justice movements' approaches to food systems change. SAN FRANCISCO,...

First patient with metastatic prostate cancer to receive 2 doses of Cu-67 SAR-bisPSMA achieves undetectable PSA level

HIGHLIGHTS Undetectable levels of Prostate Specific Antigen (PSA) have been reported from the first patient with metastatic castrate-resistant prostate cancer (mCRPC) to ever receive two...

Latest articles